Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Yonghe Ding, Ke Du, Yujuan Niu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13

Showing 13 citing articles:

Efficacy of Dexrazoxane in Cardiac Protection in Pediatric Patients Treated With Anthracyclines
Parya Rahimi, Behsheed Barootkoob, Ahmed ElHashash, et al.
Cureus (2023)
Open Access | Times Cited: 18
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1151-1151
Open Access | Times Cited: 5
Revolutionising Cardio-Oncology Care with Precision Genomics
Jun Hua Chong, Charles Chuah, Caroline Lee
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2052-2052
Open Access
SNP’s use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic
Hebatallah Ahmed Mohamed Moustafa, Walaa A. El‐Dakroury, Alaa Ashraf, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study
Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, et al.
Cardio-Oncology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Cardioprotective strategies in the management of chemotherapy-induced cardiotoxicity: Current approaches and future directions
Zeineb Al-Hasnawi, Haroon Hasan, Jaafar Mohammed Abdul Azeez, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 12, pp. 7212-7220
Open Access | Times Cited: 3
The Role of Pharmacogenomics in Drug-Induced Cardiovascular Toxicity
Ranko Škrbić, Milica Gajić Bojić, Miloš P. Stojiljković
Advances in biochemistry in health and disease (2024), pp. 453-476
Closed Access | Times Cited: 2
Early detection of anthracycline-induced cardiotoxicity
Weimin Feng, Qingchen Wang, Yuan Tan, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120000-120000
Open Access | Times Cited: 2
Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence
Ming-ming Ni, Jufei Yang, Jing Miao, et al.
Clinical Genetics (2023) Vol. 105, Iss. 2, pp. 115-129
Closed Access | Times Cited: 3
Lapatinib combined with doxorubicin causes dose-dependent cardiotoxicity partially through activating the p38MAPK signaling pathway in zebrafish embryos
Ke Du, Yuting Liu, Lu Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116637-116637
Open Access
Breast Cancer and Therapy-Related Cardiovascular Toxicity
Hui‐Jeong Hwang, Sang‐Ah Han, Il Suk Sohn
Journal of Breast Cancer (2024) Vol. 27, Iss. 3, pp. 147-147
Open Access
Genetic predictors of cardiovascular toxicity in oncohematological patients
G. R. Gimatdinova, О. Е. Данилова, И. Л. Давыдкин, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 10, pp. 6081-6081
Open Access
Molecular genetic markers of chemotherapy-induced cardiotoxicity in patients with oncohematological diseases (review)
Yu. S. Milyutkina, A. S. Sustretov, Л. В. Лимарева
Advances in molecular oncology (2023) Vol. 10, Iss. 4, pp. 86-96
Open Access
Page 1

Scroll to top